Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cezary Cybulski

Showing results (11-20 of 304) with videos related to

Pageof 31
Sort By:
Folia Histochemica Et Cytobiologica|April 15, 2008
Antigens HLA-G, sHLA- G and sHLA- class I in reproductive failureOlimpia Sipak-Szmigiel, Elzbieta Ronin-Walknowska, Cezary Cybulski, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|November 20, 2012
KRAS mutation testing in colorectal cancer as an example of the pathologist's role in personalized targeted therapy: a practical approachPaweł Domagała, Jolanta Hybiak, Violetta Sulżyc-Bielicka, et al.
Molecular Biology Reports|September 26, 2013
Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer familiesHelena Rudnicka, Tadeusz Debniak, Cezary Cybulski, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|May 10, 2003
Retinal function in the von Hippel-Lindau diseaseWojciech Lubiński, Karol Krzystolik, Cezary Cybulski, et al.
Familial Cancer|April 29, 2014
BRCA1 founder mutations compared to ovarian cancer in BelarusAlena Savanevich, Oleg Oszurek, Jan Lubiński, et al.
Cancers|December 16, 2020
CA125 and Ovarian Cancer: A Comprehensive ReviewParsa Charkhchi, Cezary Cybulski, Jacek Gronwald, et al.
Endokrynologia Polska|November 5, 2010
Case report of a woman with monoclonal gammapathy and papillary thyroid carcinoma, diagnosed because of detection of CHEK2 (I157T) mutation in genetic examinationsKatarzyna Lizis-Kolus, Aldona Kowalska, Beata Kozak-Klonowska, et al.
Journal of Applied Genetics|August 19, 2003
Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancersBohdan Górski, Tadeusz Debniak, Anna Jakubowska, et al.
Melanoma Research|April 2, 2004
Rarity of germline 1100delC mutation in CHK2 in patients with malignant melanoma of the skinTadeusz Debniak, Bohdan Górski, Cezary Cybulski, et al.
Cancer Genetics and Cytogenetics|April 27, 2010
A simple method of investigating mutations in CHEK2 by DHPLC: a study of the German populations of Saxony, Saxony-Anhalt, and ThuringiaUlrike Scharrer, Marzena Skrzypczak-Zielinska, Weronika Wituszynska, et al.
Pageof 31

Showing results (11-20 of 304) with videos related to

Sort By:
Pageof 31
Folia Histochemica Et Cytobiologica|April 15, 2008
Antigens HLA-G, sHLA- G and sHLA- class I in reproductive failureOlimpia Sipak-Szmigiel, Elzbieta Ronin-Walknowska, Cezary Cybulski, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|November 20, 2012
KRAS mutation testing in colorectal cancer as an example of the pathologist's role in personalized targeted therapy: a practical approachPaweł Domagała, Jolanta Hybiak, Violetta Sulżyc-Bielicka, et al.
Molecular Biology Reports|September 26, 2013
Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer familiesHelena Rudnicka, Tadeusz Debniak, Cezary Cybulski, et al.
Documenta Ophthalmologica. Advances in Ophthalmology|May 10, 2003
Retinal function in the von Hippel-Lindau diseaseWojciech Lubiński, Karol Krzystolik, Cezary Cybulski, et al.
Familial Cancer|April 29, 2014
BRCA1 founder mutations compared to ovarian cancer in BelarusAlena Savanevich, Oleg Oszurek, Jan Lubiński, et al.
Cancers|December 16, 2020
CA125 and Ovarian Cancer: A Comprehensive ReviewParsa Charkhchi, Cezary Cybulski, Jacek Gronwald, et al.
Endokrynologia Polska|November 5, 2010
Case report of a woman with monoclonal gammapathy and papillary thyroid carcinoma, diagnosed because of detection of CHEK2 (I157T) mutation in genetic examinationsKatarzyna Lizis-Kolus, Aldona Kowalska, Beata Kozak-Klonowska, et al.
Journal of Applied Genetics|August 19, 2003
Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancersBohdan Górski, Tadeusz Debniak, Anna Jakubowska, et al.
Melanoma Research|April 2, 2004
Rarity of germline 1100delC mutation in CHK2 in patients with malignant melanoma of the skinTadeusz Debniak, Bohdan Górski, Cezary Cybulski, et al.
Cancer Genetics and Cytogenetics|April 27, 2010
A simple method of investigating mutations in CHEK2 by DHPLC: a study of the German populations of Saxony, Saxony-Anhalt, and ThuringiaUlrike Scharrer, Marzena Skrzypczak-Zielinska, Weronika Wituszynska, et al.
Pageof 31